Krebs Biochemicals & Industr Cash Flow Annual

Trade
BSE: 524518 | NSE: KREBSBIO | ISIN: INE268B01013 | Sector: Biotechnology & Drugs
98.53 +15.81 (19.11%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line -19.73-24.69-44.53-28.36
Depreciation/ Depletion 6.776.566.305.12
Non- Cash Items 5.123.265.116.55
Changesin Working Capital 10.15-9.8415.902.11
Cashfrom Operating Activities 2.30-24.71-17.22-14.57
Capital Expenditures -9.42-15.16-27.08-25.51
Other Investing Cash Flow Items Total 1.602.514.182.96
Cashfrom Investing Activities -7.82-12.65-22.90-22.55
Financing Cash Flow Items -4.69-2.97-5.39-6.28
Issuance( Retirement)of Stock Net 0.000.0012.5110.45
Issuance( Retirement)of Debt Net 10.2540.3232.3833.49
Cashfrom Financing Activities 5.5637.3439.5137.66
Net Changein Cash 0.05-0.01-0.610.54
Cash Interest Paid 4.692.975.396.28
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts